Clinical Trials Browser

Mental Disorders, Neurologic Manifestations, Neuroma, Acoustic, Neurofibromatosis 2, Neurofibromatoses, Genetic Diseases, Inborn, Hearing Loss, Rare Diseases

NCT02084927 2014-03-12

Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery

Phase 1 Unknown

62 enrolled

CNS

Meningioma, Neurologic Manifestations

NCT00964743 2013-09-09

Depocyt® With Sorafenib in Neoplastic Meningitis

Phase NA Terminated

2 enrolled 6 charts

BreastCNS

Breast Neoplasms, Neurologic Manifestations, Meningeal Carcinomatosis

NCT00762255 2013-07-25

A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma

Phase 1 Completed

19 enrolled

CNS

Glioblastoma, Neurologic Manifestations

NCT00879073 2012-12-18

Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors

Phase 1 Terminated

12 enrolled

CNS

Brain Neoplasms, Neurologic Manifestations

NCT00251797 2010-01-07

A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors

Phase 1 Completed

10 enrolled

CNS

Brain Neoplasms, Neoplasms, Neurologic Manifestations, Central Nervous System Neoplasms

NCT00365222 2009-01-22

Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma

Phase 2 Terminated

1 enrolled

CNSSarcoma

Brain Neoplasms, Glioblastoma, Neurologic Manifestations, Gliosarcoma

Clinical Trials

EViDENCE-BT

LOC-R01

Carboplatin and Bevacizumab for Recurrent Ependymoma

Study of MT027 in Patients with Brain, Meninges, and Spinal Cord Metastatic Solid Tumors

Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma

Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases

Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas

MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning

A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)

ESIBAC

Tx-Treatment

Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2